Winway Health Desk

Blue Cross and Blue Shield of Kansas City has filed a lawsuit accusing GS Labs, a provider of Covid-19 testing, of duping insurers into...

More than six months after the federal hospital price transparency rule went into effect, few facilities are fully compliant. Last week, The Washington Post...

In response to the coronavirus pandemic knocking Shingrix off its juggernaut course, GlaxoSmithKline plans a “relaunch” to get the rising star vaccine back on...

  Bristol Myers Squibb is withdrawing its blockbuster cancer immunotherapy from use in liver cancer, the latest drug pulled from the market amid broader FDA...

Officials may have concerns about JAK inhibitor safety overall, but the case for Incyte's ruxolitinib cream in atopic dermatitis looks good, experts convened by the Institute for...

According to the Association of American Medical Colleges, there will be an estimated shortage of between 37,800 and 124,000 primary and specialty-care physicians by...

With 39 agencies now under its collective umbrella, there aren’t many pharma marketing challenges that the new IPG Health can’t address. And that’s the...

When the Biden administration eventually makes its decision over whether Medicare will cover the controversial and costly Alzheimer’s drug Aduhelm, Biogen shouldn’t be the...

For nearly four years, pharmaceutical heavyweights Johnson & Johnson and Pfizer have sparred in court over competitive dynamics of the biosimilar industry, demanding the attention...

  An Incyte drug developed to treat a rare type of anal cancer still has a shot at FDA approval, but the company needs to...